- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05885945
Diaphragmmatic Muscle Strength and Balance in Women With Dysmenorhea (Dysmenorhea)
January 26, 2024 updated by: Felipe León Morillas, Catholic University of Murcia
Analysis of stabilometric and respiratory variables in patients with dysmenorrhea during the first day of the menstrual cycle and any other day outside the cycle.
Study Overview
Status
Completed
Conditions
Detailed Description
Sociodemographic variables such as age, height, body mass index.
Respiratory variables such as maximum inspiratory pressure (MIP), MIP reference %, and MIP predictive value.
Stabilometric variables we will measure the balance in condition of eyes open and eyes closed bipodal support and eyes open in monopodal support
Study Type
Observational
Enrollment (Actual)
23
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Murcia
-
Guadalupe, Murcia, Spain, 30107
- University Catholic of Murcia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Women with primary dysmenorrhea
Description
Inclusion Criteria:
- Adult women with primary dysmenorrhea.
- Not having had any type of childbirth (natural, caesarean section, etc).
- Not be positive in COVID. Antigen test in the last 24 hours or negative PCR in the last 48 hours.
Exclusion Criteria:
- Receive medical treatment during research.
- Have any orthopedic, neurological or systemic disease diagnosed other than primary dysmenorrhea.
- Be in follow-up with any medical treatment that does not be primary dysmenorrhea
- Women with a history of trauma or surgical treatment who involve the musculoskeletal system in the last year.
- Use of analgesics in the last 48 hours.
- Consumption of alcohol in the last 24 hours.
- Have a history or suspicion of pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
dysmenorrhea
primary dysmenorrhea
|
|
control
control not pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Balance
Time Frame: 2 months
|
stabilometric variables in bipodal and monopodal support
|
2 months
|
|
diaphragmatic muscle strength
Time Frame: 2 months
|
diaphragmatic muscle force through the maximum inspiratory pressure in the mouth
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sociodemographic variables
Time Frame: 2 monsths
|
sociodemographic variables such as age, body mass index, personal data record, and data record related to pain and dysmenorrhea
|
2 monsths
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Felipe León-Morillas, Catholic University of Murcia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2023
Primary Completion (Actual)
June 14, 2023
Study Completion (Actual)
July 31, 2023
Study Registration Dates
First Submitted
May 23, 2023
First Submitted That Met QC Criteria
May 23, 2023
First Posted (Actual)
June 2, 2023
Study Record Updates
Last Update Posted (Actual)
January 29, 2024
Last Update Submitted That Met QC Criteria
January 26, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TC-01/23
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dysmenorrhea Primary
-
Ankara UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruiting
-
University of SharjahNot yet recruiting
-
Cairo UniversityRecruitingPrimary DysmenorrheaEgypt
-
Cairo UniversityCompletedPrimary DysmenorrheaEgypt
-
Camilo Jose Cela UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingPrimary DysmenorrheaEgypt
-
Rana Salem Abdelghany AliCompletedPrimary DysmenorrheaEgypt
-
University of HailHealth Education Research Foundation (HERF)Recruiting
-
Dr. Mehak NaeemUniversity of Health Sciences LahoreRecruiting
-
ApexCPG LLCNot yet recruitingPrimary Dysmenorrhea | Menstural CrampsIndia